In the BC-free individuals from the validation dataset, we observed that the methylation levels of KCNQ1, KCNQ1OT1, and PHLDA2 did not change significantly with ages ranging from 25 to 78 years (Figure S6). Here, PHLDA2 is linked to breast cancer.